These Healthcare stocks are trading higher:
-Kindred Biosciences Inc (KIN) stock is trading at $7.08, a gain of $1.64, or 28.2%, on high volume. Kindred Biosciences gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $11.25.
-Zomedica Corp (ZOM) stock is trading at $1.02, a gain of $0.18, or 23.75%, on high volume. Zomedica Pharmaceuticals Corp gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Sell.
-Vascular Biogenics Ltd (VBLT) stock is trading at $2.85, an increase of $0.46, or 18.41%, on high volume. Vascular Biogen. Ord gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.20.
-Xeris Pharmaceuticals Inc (XERS) stock is trading at $3.75, a gain of $0.5, or 15.43%, on high volume. Xeris Pharmaceuticals Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.33.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Sellas Life Sciences Group Inc (SLS) stock is trading at $11.05, a loss of $1.55, or 11.27%, on high volume. Sellas Life Sciences Group Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $12.00.
-Replimune Group Inc (REPL) stock is trading at $32.14, a loss of $4.11, or 11.03%, on high volume. Replimune Group Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $57.00.
-Soleno Therapeutics Inc (SLNO) stock is trading at $1.21, a drop of $0.12, or 8.71%, on moderate volume. Soleno Therapeutics Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.50.
-Impel Neuropharma Inc (IMPL) stock is trading at $9.53, a decline of $0.87, or 8.37%, on low volume. Impel Neuropharma Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $29.33.
